BackCastle Biosciences Overview

Castle Biosciences Accounts Payable

Track Castle Biosciences's accounts payable ($9.7M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Accounts Payable
$9.67M
↓ 26.65% YoYΔ $-3.51M vs prior year quarter

Peer average / median

Loading

Castle Biosciences Accounts Payable History

Loading

Castle Biosciences vs. peers: Accounts Payable Comparison

Loading

Castle Biosciences Accounts Payable Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Castle Biosciences (CSTL) FAQ

Castle Biosciences (CSTL) currently reports a accounts payable of $9.7M as of June 2026. That compares with $13M in the prior-year period — down 26.7% year over year. Use the charts on this page to explore Castle Biosciences's accounts payable history and peer comparisons.

Castle Biosciences's accounts payable decreased from $13M to $9.7M — a 26.7% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Castle Biosciences reported $9.7M in accounts payable as of June 2026. That compares with $13M in the prior-year period — down 26.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current accounts payable of $9.7M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Castle Biosciences, and consider following CSTL for alerts when major investors trade the stock.

Castle Biosciences is classified in the Healthcare sector. On accounts payable, it currently shows $9.7M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CSTL with unrelated industries.